Metastatic stage D2 Prostatic carcinoma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01128 | Bicalutamide | An androgen receptor inhibitor used to treat Stage D2 metastatic carcinoma of the prostate. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01128 | Bicalutamide | Androgen receptor | target |
| DB01128 | Bicalutamide | Cytochrome P450 3A4 | enzyme |
| DB01128 | Bicalutamide | Cytochrome P450 2C19 | enzyme |
| DB01128 | Bicalutamide | Cytochrome P450 2C9 | enzyme |
| DB01128 | Bicalutamide | Cytochrome P450 2D6 | enzyme |
| DB01128 | Bicalutamide | P-glycoprotein 1 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|